NFKB1 and ovarian carcinoma: These results suggest that the pretreatment of cells with genistein sensitized ovarian cancer cells, especially the drug-resistant cells to cisplatin, taxotere, and gemcitabine induced growth inhibition and induction of apoptotic cell death, which is believed to be contributed by the inhibition of survival factors, and inactivation of the DNA binding activity of NF-κB.